Get started
Nykode Therapeutics ASANykode Therapeutics ASANykode Therapeutics ASA

Nykode Therapeutics ASA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

5VB chart


Full chart

5VB upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪45.29 M‬ EUR
Dividend yield (indicated)
61.54%
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.05 EUR
Net income (FY)
‪−35.42 M‬ EUR
Revenue (FY)
‪7.92 M‬ EUR
Shares float
‪150.41 M‬
Beta (1Y)
1.63

Employees


Employees (FY)
139
Change (1Y)
−34 −19.65%
Revenue / Employee (1Y)
‪56.97 K‬ EUR
Net income / Employee (1Y)
‪−254.80 K‬ EUR

About Nykode Therapeutics ASA


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Michael Thyrring Engsig
Website
nykode.com
Headquarters
Oslo
Founded
2006
ISIN
NO0010714785
FIGI
BBG00XZYM5G1
Nykode Therapeutics ASA is a clinical-stage biopharmaceutical company which engages in discovering and developing of novel immunotherapies. It focuses on developing field of individualized cancer neoantigen vaccines by using the Vaccibody technology to generate therapeutics to treat cancer. The company was founded by Inger Sandlie and Agnete Brunsvik Fredriksen on November 22, 2006 and is headquartered in Oslo, Norway.

Check out other big names from the same industry as 5VB.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

5VB news



Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 5VB is 0.14 EUR — it hasn't changed in the past 24 hours. Watch Nykode Therapeutics ASA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Nykode Therapeutics ASA stocks are traded under the ticker 5VB.
5VB stock has risen by 23.89% compared to the previous week, the month change is a 18.85% rise, over the last year Nykode Therapeutics ASA has showed a −72.19% decrease.
We've gathered analysts' opinions on Nykode Therapeutics ASA future price: according to them, 5VB price has a max estimate of 0.15 EUR and a min estimate of 0.15 EUR. Watch 5VB chart and read a more detailed Nykode Therapeutics ASA stock forecast: see what analysts think of Nykode Therapeutics ASA and suggest that you do with its stocks.
5VB reached its all-time high on Feb 17, 2021 with the price of 8.89 EUR, and its all-time low was 0.09 EUR and was reached on Aug 29, 2025. View more price dynamics on 5VB chart.
See other stocks reaching their highest and lowest prices.
5VB stock is 58.09% volatile and has beta coefficient of 1.63. Track Nykode Therapeutics ASA stock price on the chart and check out the list of the most volatile stocks — is Nykode Therapeutics ASA there?
Today Nykode Therapeutics ASA has the market capitalization of ‪45.29 M‬, it has decreased by −14.36% over the last week.
Yes, you can track Nykode Therapeutics ASA financials in yearly and quarterly reports right on TradingView.
Nykode Therapeutics ASA is going to release the next earnings report on Nov 26, 2025. Keep track of upcoming events with our Earnings Calendar.
5VB net income for the last quarter is ‪743.46 K‬ EUR, while the quarter before that showed ‪−1.40 M‬ EUR of net income which accounts for 152.96% change. Track more Nykode Therapeutics ASA financial stats to get the full picture.
Yes, 5VB dividends are paid annually. The last dividend per share was 0.09 EUR. As of today, Dividend Yield (TTM)% is 61.54%. Tracking Nykode Therapeutics ASA dividends might help you take more informed decisions.
As of Sep 3, 2025, the company has 139 employees. See our rating of the largest employees — is Nykode Therapeutics ASA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Nykode Therapeutics ASA EBITDA is ‪−30.31 M‬ EUR, and current EBITDA margin is −522.63%. See more stats in Nykode Therapeutics ASA financial statements.
Like other stocks, 5VB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nykode Therapeutics ASA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nykode Therapeutics ASA technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nykode Therapeutics ASA stock shows the sell signal. See more of Nykode Therapeutics ASA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.